Does hormone therapy impact cognition in patients with prostate cancer? A systematic review and meta-analysis.
Antoine BouéFlorence JolyJustine LequesneMarie LangePublished in: Cancer (2024)
There is no consensus on the cognitive impairment induced by hormone therapy for prostate cancer, despite the implications for patients' care and daily life. This synthesis of published studies demonstrated an increase in perceived cognitive difficulties but did not prove a decline in cognitive performance during treatment.
Keyphrases
- prostate cancer
- end stage renal disease
- cognitive impairment
- radical prostatectomy
- ejection fraction
- chronic kidney disease
- newly diagnosed
- physical activity
- healthcare
- peritoneal dialysis
- palliative care
- depressive symptoms
- social support
- stem cells
- randomized controlled trial
- quality improvement
- systematic review
- white matter
- mesenchymal stem cells
- replacement therapy